TPL2/COT/MAP3K8 (TPL2) Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth
2011

TPL2 Activation and Prostate Cancer Growth

publication Evidence: high

Author Information

Author(s): Jeong Joseph H., Bhatia Ayesha, Toth Zsolt, Oh Soohwan, Inn Kyung-Soo, Liao Chun-Peng, Roy-Burman Pradip, Melamed Jonathan, Coetzee Gerhard A., Jung Jae U.

Primary Institution: USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California

Hypothesis

Is TPL2 a key driver of androgen depletion-independent prostate cancer growth?

Conclusion

TPL2 kinase plays a critical role in promoting androgen depletion-independent prostate cancer progression.

Supporting Evidence

  • TPL2 is upregulated in androgen depletion-independent prostate cancers.
  • Suppressing TPL2 reduces prostate cancer cell growth under low androgen conditions.
  • High frequency of TPL2 overexpression in human ADI prostate cancer samples suggests its potential as a treatment target.

Takeaway

This study found that a protein called TPL2 helps prostate cancer grow even when testosterone is low, which is important for finding new treatments.

Methodology

The study screened a library of activated human kinases to identify TPL2's role in prostate cancer growth.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016205

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication